- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06719258
Evaluation of Gas Humidification Practices in Patients Under Invasive Mechanical Ventilation (FP950)
Evaluation of Gas Humidification Practices in Patients Under Invasive Mechanical Ventilation: Benefit of the F & P950 Heated Humidifier: Comparison With the MR 850 on Clinical Events of Under-humidification
When mechanical ventilation is initiated, a humidification method should be chosen. There is two methods: heat and humidity exchanger filters or heated humidity. The second method is recognized to be more efficient, but many external factors can influence its performance. Insufficient humidity results in observable problems, such as difficult management of respiratory secretions.
The study compare two heated humidifiers already used in ICU.
Data will be collected retrospectively from June 1, 2021.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: François Lellouche
- Phone Number: 3572 418-656-8711
- Email: francois.lellouche@criucpq.ulaval.ca
Study Contact Backup
- Name: Pierre-Alexandre Bouchard
- Phone Number: 2712 418-656-8711
- Email: pierre-alexandre.bouchard@criucpq.ulaval.ca
Study Locations
-
-
Quebec
-
Québec, Quebec, Canada, G1V4G5
- Recruiting
- Institut Universitaire de Cardiologie et de Pneumologie de Quebec
-
Contact:
- Francois Lellouche
- Phone Number: 418-656-8711
- Email: francois.lellouche@criucpq.ulaval.ca
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- ≥ 18 years old
- Admitted to intensive care
- Under invasive mechanical ventilation with the usual indications for the use of a heated humidifier (prolonged invasive mechanical ventilation and / or protective ventilation requiring high respiratory rates.
Exclusion Criteria:
- Mechanical venitilation immediately after surgery (<24h)
- Imminent extubation or planned intubation of very short duration (<24h)
- Enrolled in the SAVE-ICU study in the group receiving volatile agents with the AnaConDa system.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
MR850
20 subjects on this heating humidifier (Fisher & Paykel MR850).
|
This humidifier will be used straight away for patients whose intubation is expected to last longer than 24 hours.
|
|
FP950
20 subjects on this heating humidifier (Fisher & Paykel FP950).
|
This humidifier will be used straight away for patients whose intubation is expected to last longer than 24 hours.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Endotracheal tube occlusion requiring emergency tube change
Time Frame: At the end of the mechanical ventilation period or at 21 days ( the first of the 2 occurred)
|
Under-humidification episodes are defined as follows: - Occurence of endotracheal tube occlusion requiring emergency tube change |
At the end of the mechanical ventilation period or at 21 days ( the first of the 2 occurred)
|
|
Bronchoscopy
Time Frame: At the end of the mechanical ventilation period or at 21 days ( the first of the 2 occurred)
|
Under-humidification episodes are defined as follows: - Occurence of performing a bronchoscopy for a suspected sub-occlusion (thick or sticky secretions), and the total number of bronchoscopies performed per patient |
At the end of the mechanical ventilation period or at 21 days ( the first of the 2 occurred)
|
|
Tracheal saline instillations
Time Frame: At the end of the mechanical ventilation period or at 21 days ( the first of the 2 occurred)
|
Under-humidification episodes are defined as follows: - Occurence of tracheal saline instillations due to sticky secretions or suspected endotracheal tube sub-occlusion |
At the end of the mechanical ventilation period or at 21 days ( the first of the 2 occurred)
|
|
Thick secretions
Time Frame: At the end of the mechanical ventilation period or at 21 days ( the first of the 2 occurred)
|
Under-humidification episodes are defined as follows: - Occurence of tracheal secretions describe at thick secretions (rated at 5 on the secretions scale used at the hospital) or "sticky secretions" if specified |
At the end of the mechanical ventilation period or at 21 days ( the first of the 2 occurred)
|
|
Change humidifier settings
Time Frame: At the end of the mechanical ventilation period or at 21 days ( the first of the 2 occurred)
|
Under-humidification episodes are defined as follows: - The number of operations required to change humidifier settings if the plate temperature is below 62 degrees Celcius (with the MR850). |
At the end of the mechanical ventilation period or at 21 days ( the first of the 2 occurred)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Other elements that may be influenced by the quality of the humidification used during mechanical ventilation
Time Frame: At the end of the mechanical ventilation period or at 21 days ( the first of the 2 occurred)
|
These data will be collected:
|
At the end of the mechanical ventilation period or at 21 days ( the first of the 2 occurred)
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2022-3714
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Respiratory Complication
-
Asst Melegnano e MartesanaEnrolling by invitationMortality | Nephrotoxicity | Respiratory Complication | Neurological Complication | Surgical Complication | Metabolic Complication | Cardiovascular ComplicationItaly
-
Eske Kvanner AasvangCompletedComplication of Surgical Procedure | Respiratory Complication | Complication of Anesthesia | Circulatory; ComplicationsDenmark
-
Uppsala UniversityNot yet recruitingMechanical Ventilation Complication | Respiratory Complication | Neurological Complication
-
Assiut UniversityCompletedRespiratory Complication | Bypass ComplicationEgypt
-
Instituto de Cardiologia do Rio Grande do SulCompletedRespiratory ComplicationBrazil
-
Medtronic - MITGTerminatedRespiratory ComplicationGermany
-
Vital USA, Inc.Clinimark, LLCCompleted
-
Sangjin ParkCompletedRespiratory ComplicationKorea, Republic of
-
Memorial Health University Medical CenterUnknownRespiratory ComplicationUnited States
-
Sangjin ParkCompleted
Clinical Trials on MR850
-
Guy's and St Thomas' NHS Foundation TrustCompletedChronic Obstructive Pulmonary Disease | Obesity Hypoventilation Syndrome | Neuromuscular Disease | Chronic Respiratory Hypercapnic FailureUnited Kingdom
-
University Hospital, Clermont-FerrandCompletedPostoperative HypoxemiaFrance